Virological events in HIV-infected patients can rise with no apparent reason. Therefore, when they appear, immunologists or medical doctors do not know whether they will produce other future virological events or
they will entail relevant clinical consequences. This paper presents the results of applying Prefurge to HIV-
infected patients’ clinical data, with the aim of obtaining rules and information about this set of clinical
trials data that will relate these kinds of virological events.Junta de Andalucía TIC-578